MiR-185-3p mimic promotes the chemosensitivity of CRC cells via AQP5

References

• Mathews MJ, Mead RN, Galizio M. Effects of N-Methyl-D-aspartate (NMDA) antagonists ketamine, methoxetamine, and phencyclidine on the odor span test of working memory in rats. Exp Clin Psychopharmacol. 2018;26:6–17.
   PubMed Web of Science ®Google Scholar
• He YJ, Meghani K, Caron MC, Yang C, Ronato DA, Bian J, Sharma A, Moore J, Niraj J, Detappe A, et al. DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells. Nature. 2018;563:522–526.
   PubMed Web of Science ®Google Scholar
• Germano G, Amirouchene-Angelozzi N, Rospo G, Bardelli A. The clinical impact of the genomic landscape of mismatch repair-deficient cancers. Cancer Discov. 2018;8:1518–1528.
   PubMed Web of Science ®Google Scholar
• Aird D, Teng T, Huang CL, Pazolli E, Banka D, Cheung-Ong K, Eifert C, Furman C, Wu ZJ, Seiler M, et al. Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators. Nat Commun. 2019;10:137.
   PubMed Web of Science ®Google Scholar
• Yin Y, Xu L, Chang Y, Zeng T, Chen X, Wang A, Groth J, Foo WC, Liang C, Hu H, et al. N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway. Mol Cancer. 2019;18:11.
   PubMed Web of Science ®Google Scholar
• Borgo C, Ruzzene M. Role of protein kinase CK2 in antitumor drug resistance. J Exp Clin Cancer Res. 2019;38:287.
   PubMed Web of Science ®Google Scholar
• Shan Z, Wei L, Yu S, Jiang S, Ma Y, Zhang C, Wang J, Gao Z, Wan F, Zhuang G, et al. Ketamine induces reactive oxygen species and enhances autophagy in SV-HUC-1 human uroepithelial cells. J Cell Physiol. 2019;234:2778–2787.
   PubMed Web of Science ®Google Scholar
• Saleem H, Kulsoom Abdul U, Kucukosmanoglu A, Houweling M, Cornelissen FMG, Heiland DH, Hegi ME, Kouwenhoven MCM, Bailey D, Wurdinger T, et al. The TICking clock of EGFR therapy resistance in glioblastoma: target Independence or target Compensation. Drug Resist Updates. 2019;43:29–37.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang H, Assaraf YG, Zhao K, Xu X, Xie J, Yang DH, Chen ZS. Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies. Drug Resist Updates. 2016;27:14–29.
   PubMed Web of Science ®Google Scholar
• Han K, Jeng EE, Hess GT, Morgens DW, Li A, Bassik MC. Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions. Nat Biotechnol. 2017;35:463–474.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.
   PubMed Web of Science ®Google Scholar
• Khalilzadeh B, Shadjou N, Kanberoglu GS, Afsharan H, de la Guardia M, Charoudeh HN, Ostadrahimi A, Rashidi MR. Advances in nanomaterial based optical biosensing and bioimaging of apoptosis via caspase-3 activity: a review. Mikrochim Acta. 2018;185:434.
   PubMed Web of Science ®Google Scholar
• Uppada SB, Gowrikumar S, Ahmad R, Kumar B, Szeglin B, Chen X, Smith JJ, Batra SK, Singh AB, Dhawan P. MASTL induces colon cancer progression and Chemoresistance by promoting Wnt/beta-catenin signaling. Mol Cancer. 2018;17:111.
   PubMed Web of Science ®Google Scholar
• Cotte AK, Aires V, Fredon M, Limagne E, Derangere V, Thibaudin M, Humblin E, Scagliarini A, de Barros JP, Hillon P, et al. Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance. Nat Commun. 2018;9:322.
   PubMed Web of Science ®Google Scholar
• Marjaneh RM, Khazaei M, Ferns GA, Avan A, Aghaee-Bakhtiari SH. The role of microRNAs in 5-FU resistance of colorectal cancer: possible mechanisms. J Cell Physiol. 2019;234:2306–2316.
   PubMed Web of Science ®Google Scholar
• Zhao P, Ma YG, Zhao Y, Liu D, Dai ZJ, Yan CY, Guan HT. MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancer. Cancer Chemother Pharmacol. 2019;84:427–439.
   PubMed Web of Science ®Google Scholar
• Cai MH, Xu XG, Yan SL, Sun Z, Ying Y, Wang BK, Tu YX. Regorafenib suppresses colon tumorigenesis and the generation of drug resistant cancer stem-like cells via modulation of miR-34a associated signaling. J Exp Clin Cancer Res. 2018;37:151.
   PubMed Web of Science ®Google Scholar
• Han X, Wu YC, Meng M, Sun QS, Gao SM, Sun H. Linarin prevents LPSinduced acute lung injury by suppressing oxidative stress and inflammation via inhibition of TXNIP/NLRP3 and NFkappaB pathways. Int J Mol Med. 2018;42:1460–1472.
   PubMed Web of Science ®Google Scholar
• Shi L, Li X, Wu Z, Li X, Nie J, Guo M, Mei Q, Han W. DNA methylation-mediated repression of miR-181a/135a/302c expression promotes the microsatellite-unstable colorectal cancer development and 5-FU resistance via targeting PLAG1. J Genet Genomics. 2018;45:205–214.
   PubMed Web of Science ®Google Scholar
• Wen Y, Liu YR, Tang TT, Pan MM, Xu SC, Ma KL, Lv LL, Liu H, Liu BC. mROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKI. Int J Biochem Cell Biol. 2018;98:43–53.
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhao Q, Zhang C, Wang G, Yao Y, Huang X, Zhan F, Zhu Y, Shi J, Chen J, et al. miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-kappaB/XIAP axis. Sci Rep. 2017;7:4194.
   PubMed Web of Science ®Google Scholar
• Ma D, Cao Y, Wang Z, He J, Chen H, Xiong H, Ren L, Shen C, Zhang X, Yan Y, et al. CCAT1 lncRNA promotes inflammatory bowel disease malignancy by destroying intestinal barrier via downregulating miR-185-3p. Inflamm Bowel Dis. 2019;25:862–874.
   PubMed Web of Science ®Google Scholar
• Uhr K, Prager-van der Smissen WJC, Heine AAJ, Ozturk B, van Jaarsveld MTM, Boersma AWM, Jager A, Wiemer EAC, Smid M, Foekens JA, et al. MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines. PLoS One. 2019;14:e0216400.
   PubMed Web of Science ®Google Scholar
• Lu ZJ, Lu LG, Tao KZ, Chen DF, Xia Q, Weng JJ, Zhu F, Wang XP, Zheng P. MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxia-inducible factor-2alpha pathway in vitro and in vivo. Mol Med Rep. 2014;10:2401–2408.
   PubMed Web of Science ®Google Scholar
• Yuan M, Zhang X, Zhang J, Wang K, Zhang Y, Shang W, Zhang Y, Cui J, Shi X, Na H, et al. DC-SIGN-LEF1/TCF1-miR-185 feedback loop promotes colorectal cancer invasion and metastasis. Cell Death Differ. 2020;27:379–395.
   PubMed Web of Science ®Google Scholar
• Afshar S, Najafi R, Sedighi Pashaki A, Sharifi M, Nikzad S, Gholami MH, Khoshghadam A, Amini R, Karimi J, Saidijam M. MiR-185 enhances radiosensitivity of colorectal cancer cells by targeting IGF1R and IGF2. Biomed Pharmacother. 2018;106:763–769.
   PubMed Web of Science ®Google Scholar
• Liao JM, Lu H. Autoregulatory suppression of c-Myc by miR-185-3p. J Biol Chem. 2011;286:33901–33909.
   PubMed Web of Science ®Google Scholar
• Liu C, Li G, Ren S, Su Z, Wang Y, Tian Y, Liu Y, Qiu Y. miR-185-3p regulates the invasion and metastasis of nasopharyngeal carcinoma by targeting WNT2B in vitro. Oncol Lett. 2017;13:2631–2636.
   PubMed Web of Science ®Google Scholar
• Borgnia M, Nielsen S, Engel A, Agre P. Cellular and molecular biology of the aquaporin water channels. Annu Rev Biochem. 1999;68:425–458.
   PubMed Web of Science ®Google Scholar
• Zhu S, Ran J, Yang B, Mei Z. Aquaporins in digestive system. Adv Exp Med Biol. 2017;969:123–130.
   PubMedGoogle Scholar
• Xu M, Xiao M, Li S, Yang B. Aquaporins in Nervous System. Adv Exp Med Biol. 2017;969:81–103.
   PubMed Web of Science ®Google Scholar
• Tsubota K, Hirai S, King LS, Agre P, Ishida N. Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjogren’s syndrome. Lancet. 2001;357:688–689.
   PubMed Web of Science ®Google Scholar
• Blaydon DC, Lind LK, Plagnol V, Linton KJ, Smith FJ, Wilson NJ, McLean WH, Munro CS, South AP, Leigh IM, et al. Mutations in AQP5, encoding a water-channel protein, cause autosomal-dominant diffuse nonepidermolytic palmoplantar keratoderma. Am J Hum Genet. 2013;93:330–335.
   PubMed Web of Science ®Google Scholar
• Adamzik M, Frey UH, Mohlenkamp S, Scherag A, Waydhas C, Marggraf G, Dammann M, Steinmann J, Siffert W, Aquaporin PJ. 5 gene promoter–1364A/C polymorphism associated with 30-day survival in severe sepsis. Anesthesiology. 2011;114:912–917.
   PubMed Web of Science ®Google Scholar
• Direito I, Madeira A, Brito MA, Soveral G. Aquaporin-5: from structure to function and dysfunction in cancer. Cell Mol Life Sci. 2016;73:1623–1640.
   PubMed Web of Science ®Google Scholar
• Zhu L, Ma N, Wang B, Wang L, Zhou C, Yan Y, He J, Ren Y. Significant prognostic values of aquaporin mRNA expression in breast cancer. Cancer Manag Res. 2019;11:1503–1515.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Jiao L, Li T, Wang H, Wei W, Qian H. Expression of AQP3 and AQP5 as a prognostic marker in triple-negative breast cancer. Oncol Lett. 2018;16:2661–2667.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Han Y, Sun G, Liu X, Jia X, Yu X. MicroRNA-325-3p inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma by down-regulation of aquaporin 5. Cell Mol Biol Lett. 2019;24:13.
   PubMed Web of Science ®Google Scholar
• Shimasaki M, Kanazawa Y, Sato K, Tsuchiya H, Ueda Y. Aquaporin-1 and −5 are involved in the invasion and proliferation of soft tissue sarcomas. Pathol Res Pract. 2018;214:80–88.
   PubMed Web of Science ®Google Scholar
• Cagini L, Balloni S, Ludovini V, Andolfi M, Matricardi A, Potenza R, Vannucci J, Siggillino A, Tofanetti FR, Bellezza G, et al. Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer. Eur J Cardio-thoracic Surg. 2017;52:1077–1082.
   PubMed Web of Science ®Google Scholar
• Li Q, Yang T, Li D, Ding F, Bai G, Wang W, Sun H. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-beta-catenin signaling pathway. Biochem Cell Biol. 2018;96:572–579.
   PubMedGoogle Scholar
• Nakaya Y, Sheng G. EMT in developmental morphogenesis. Cancer Lett. 2013;341:9–15.
   PubMed Web of Science ®Google Scholar
• Smith BN, Bhowmick NA. Role of EMT in metastasis and therapy resistance. J Clin Med. 2016;5:17.
   Web of Science ®Google Scholar
• Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, Xiong B. M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling. Onco Targets Ther. 2019;12:3051–3063.
   PubMed Web of Science ®Google Scholar
• Quan Q, Zhong F, Wang X, Chen K, Guo L. PAR2 Inhibition Enhanced the Sensitivity of Colorectal Cancer Cells to 5-FU and Reduced EMT Signaling. Oncol Res. 2019;27:779–788.
   PubMed Web of Science ®Google Scholar
• Wang W, Li Q, Yang T, Li D, Ding F, Sun H, Bai G. Anti-cancer effect of Aquaporin 5 silencing in colorectal cancer cells in association with inhibition of Wnt/beta-catenin pathway. Cytotechnology. 2018;70:615–624.
   PubMed Web of Science ®Google Scholar
• Chen C, Ma T, Zhang C, Zhang H, Bai L, Kong L, Luo J. Down-regulation of aquaporin 5-mediated epithelial-mesenchymal transition and anti-metastatic effect by natural product Cairicoside E in colorectal cancer. Mol Carcinog. 2017;56:2692–2705.
   PubMed Web of Science ®Google Scholar
• He Z, Dong W, Hu J, Ren X. AQP5 promotes hepatocellular carcinoma metastasis via NF-kappaB-regulated epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2017;490:343–348.
   PubMed Web of Science ®Google Scholar